drugset / Trial / NCT01034254

Summary

This project is designed to assess the efficacy of immunizing women during pregnancy with influenza vaccine on the health of these women during their pregnancy and for 6 months post-partum as well as on the health of their newborn infants during the first 6 months of life. It will be conducted in Sarlahi District in southern Nepal, a rural area where a number of large scale randomized trials have been conducted over the past 20 years.

Timeline

Start
2010-11
Primary completion
2014-05
Completion
2017-10

Outcome

Met primary endpoint

paper Immunisation reduced maternal febrile influenza-like illness with an overall efficacy of 19% (95% CI 1 to 34) in the combined cohorts; PMID 28522338 ↗

paper For laboratory-confirmed influenza infections in infants aged 0-6 months, immunisation had an overall efficacy for the combined cohorts of 30% (95% CI 5 to 48); PMID 28522338 ↗

paper Maternal immunisation reduced the rates of low birthweight by 15% (95% CI 3-25) in both cohorts combined. PMID 28522338 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza vaccine Vaccine — —

Indications